Literature DB >> 18413613

The evolutionarily conserved G protein-coupled receptor SREB2/GPR85 influences brain size, behavior, and vulnerability to schizophrenia.

Mitsuyuki Matsumoto1, Richard E Straub, Stefano Marenco, Kristin K Nicodemus, Shun-Ichiro Matsumoto, Akihiko Fujikawa, Sosuke Miyoshi, Miwako Shobo, Shinji Takahashi, Junko Yarimizu, Masatoshi Yuri, Masashi Hiramoto, Shuji Morita, Hiroyuki Yokota, Takeshi Sasayama, Kazuhiro Terai, Masayasu Yoshino, Akira Miyake, Joseph H Callicott, Michael F Egan, Andreas Meyer-Lindenberg, Lucas Kempf, Robyn Honea, Radha Krishna Vakkalanka, Jun Takasaki, Masazumi Kamohara, Takatoshi Soga, Hideki Hiyama, Hiroyuki Ishii, Ayako Matsuo, Shintaro Nishimura, Nobuya Matsuoka, Masato Kobori, Hitoshi Matsushime, Masao Katoh, Kiyoshi Furuichi, Daniel R Weinberger.   

Abstract

The G protein-coupled receptor (GPCR) family is highly diversified and involved in many forms of information processing. SREB2 (GPR85) is the most conserved GPCR throughout vertebrate evolution and is expressed abundantly in brain structures exhibiting high levels of plasticity, e.g., the hippocampal dentate gyrus. Here, we show that SREB2 is involved in determining brain size, modulating diverse behaviors, and potentially in vulnerability to schizophrenia. Mild overexpression of SREB2 caused significant brain weight reduction and ventricular enlargement in transgenic (Tg) mice as well as behavioral abnormalities mirroring psychiatric disorders, e.g., decreased social interaction, abnormal sensorimotor gating, and impaired memory. SREB2 KO mice showed a reciprocal phenotype, a significant increase in brain weight accompanying a trend toward enhanced memory without apparent other behavioral abnormalities. In both Tg and KO mice, no gross malformation of brain structures was observed. Because of phenotypic overlap between SREB2 Tg mice and schizophrenia, we sought a possible link between the two. Minor alleles of two SREB2 SNPs, located in intron 2 and in the 3' UTR, were overtransmitted to schizophrenia patients in a family-based sample and showed an allele load association with reduced hippocampal gray matter volume in patients. Our data implicate SREB2 as a potential risk factor for psychiatric disorders and its pathway as a target for psychiatric therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413613      PMCID: PMC2299221          DOI: 10.1073/pnas.0710717105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Target validation of G-protein coupled receptors.

Authors:  Alan Wise; Katy Gearing; Stephen Rees
Journal:  Drug Discov Today       Date:  2002-02-15       Impact factor: 7.851

2.  Cloning and localization of rgpr85 encoding rat G-protein-coupled receptor.

Authors:  Jongrye Jeon; Changmee Kim; Woong Sun; Hyesun Chung; Sun-Hwa Park; Hyun Kim
Journal:  Biochem Biophys Res Commun       Date:  2002-11-08       Impact factor: 3.575

3.  An evolutionarily conserved G-protein coupled receptor family, SREB, expressed in the central nervous system.

Authors:  M Matsumoto; T Saito; J Takasaki; M Kamohara; T Sugimoto; M Kobayashi; M Tadokoro; S Matsumoto; T Ohishi; K Furuichi
Journal:  Biochem Biophys Res Commun       Date:  2000-06-07       Impact factor: 3.575

Review 4.  Constitutively activated G protein-coupled receptors: a novel approach to CNS drug discovery.

Authors:  Frédérique Menzaghi; Dominic P Behan; Derek T Chalmers
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2002-02

5.  Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

Authors:  Michael F Egan; Richard E Straub; Terry E Goldberg; Imtiaz Yakub; Joseph H Callicott; Ahmad R Hariri; Venkata S Mattay; Alessandro Bertolino; Thomas M Hyde; Cynthia Shannon-Weickert; Mayada Akil; Jeremy Crook; Radha Krishna Vakkalanka; Rishi Balkissoon; Richard A Gibbs; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

6.  Hippocampal synaptic plasticity in mice overexpressing an embryonic subunit of the NMDA receptor.

Authors:  S Okabe; C Collin; J M Auerbach; N Meiri; J Bengzon; M B Kennedy; M Segal; R D McKay
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

7.  The brain-specific G-protein coupled receptor GPR85 with identical protein sequence in man and mouse maps to human chromosome 7q31.

Authors:  S Hellebrand; H C Schaller; T Wittenberger
Journal:  Biochim Biophys Acta       Date:  2000-09-07

8.  A conserved mRNA expression profile of SREB2 (GPR85) in adult human, monkey, and rat forebrain.

Authors:  Mitsuyuki Matsumoto; Senda Beltaifa; Cynthia Shannon Weickert; Mary M Herman; Thomas M Hyde; Richard C Saunders; Barbara K Lipska; Daniel R Weinberger; Joel E Kleinman
Journal:  Brain Res Mol Brain Res       Date:  2005-07-29

Review 9.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

10.  Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q.

Authors: 
Journal:  Hum Mol Genet       Date:  2001-04-15       Impact factor: 6.150

View more
  25 in total

Review 1.  Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.

Authors:  Susan B Powell; Martin Weber; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 3.  Drug targets: single-cell transcriptomics hastens unbiased discovery.

Authors:  Tamas Bartfai; Peter T Buckley; James Eberwine
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

Review 4.  Neuro-psychopharmacological perspective of Orphan receptors of Rhodopsin (class A) family of G protein-coupled receptors.

Authors:  Muhammad Zahid Khan; Ling He
Journal:  Psychopharmacology (Berl)       Date:  2017-03-13       Impact factor: 4.530

5.  Evolutionary Loss of Genomic Proximity to Conserved Noncoding Elements Impacted the Gene Expression Dynamics During Mammalian Brain Development.

Authors:  Meenakshi Bagadia; Keerthivasan Raanin Chandradoss; Yachna Jain; Harpreet Singh; Mohan Lal; Kuljeet Singh Sandhu
Journal:  Genetics       Date:  2019-02-22       Impact factor: 4.562

Review 6.  Constitutional mechanisms of vulnerability and resilience to nicotine dependence.

Authors:  N Hiroi; D Scott
Journal:  Mol Psychiatry       Date:  2009-02-24       Impact factor: 15.992

7.  Effect of schizophrenia risk-associated alleles in SREB2 (GPR85) on functional MRI phenotypes in healthy volunteers.

Authors:  Eugenia Radulescu; Fabio Sambataro; Venkata S Mattay; Joseph H Callicott; Richard E Straub; Mitsuyuki Matsumoto; Daniel R Weinberger; Stefano Marenco
Journal:  Neuropsychopharmacology       Date:  2012-09-12       Impact factor: 7.853

Review 8.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

Review 9.  Adult Neurogenesis and Psychiatric Disorders.

Authors:  Eunchai Kang; Zhexing Wen; Hongjun Song; Kimberly M Christian; Guo-Li Ming
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

Review 10.  [Are psychic disorders specifically human?].

Authors:  M Brüne
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.